Background
==========

Intermittent claudication is a symptom of peripheral arterial disease (PAD), and is described as muscle pain in the lower extremities that is produced by exercise and relieved in rest. Patients with intermittent claudication have limited exercise and walking capacity, which reduces their functional capacity\[[@B1]\].

Treadmill testing is a common way to quantify the grade of functional impairment. The Royal Dutch Society for Physiotherapists recommends the administration of treadmill tests to all patients with intermittent claudication, both to objectively document the degree of functional impairment, and to evaluate therapy effect\[[@B2]\].

In general, two distances are measured during treadmill testing of patients with intermittent claudication. First is the distance walked at the onset of claudication pain, also known as the initial claudication distance (ICD), or pain-free walking distance. The second measurement is the distance at which claudication pain becomes so severe that the patient is forced to stop, also known as the absolute claudication distance (ACD), or maximal walking distance \[[@B2]-[@B6]\]. In the literature, both ICD and ACD are used to classify the degree of functional impairment. Both distances have been shown to be reliable measurements with good reproducibility. ICD appears to be less reliable in comparison with ACD \[[@B7]-[@B13]\].

In patients with intermittent claudication both ICD and ACD correlate with different quality of life domains of the EuroQol\[[@B14]\], the Short-form-36\[[@B15],[@B16]\], and several disease specific questionnaires \[[@B17]-[@B19]\]. However, the definition of both ICD and ACD is not correspondent with distances a patient would walk in daily life. Although most patients will continue to walk after appearance of the first signs of pain, few will walk until their maximum pain threshold is reached during the course of daily activities.

For this reason, the distance at which a patient prefers to stop because of claudication pain may be a better instrument by which to measure the functional impairment of patients with intermittent claudication. Bendermacher et al\[[@B20]\] first used \"the distance at which a patient prefers to stop because of claudication pain\". We define this distance as the functional claudication distance (FCD).

We conducted this study, since the reliability and validity of FCD have never been tested. Furthermore we want to compare reliability and validity of FCD with both ICD and ACD to determine the value of FCD for testing functional impairment in patients with intermittent claudication.

Methods
=======

Patients
--------

Patients with intermittent claudication, following a supervised exercise program, were recruited from private physiotherapy practices in the Southern part of the Netherlands. Inclusion criteria were intermittent claudication with an ACD of \< 1600 meters on a standard treadmill test. Patients had to have followed at least 3 months of community based supervised exercise therapy according to the guidelines of the Royal Dutch Society of Physiotherapy to rule out therapy effect between the 2 study measurements. Exclusion criteria were the inability to walk on the standard treadmill protocol, serious cardiopulmonary comorbidity (NYHA 3 and 4)\[[@B21]\] and reasons for discontinuing the treadmill test other than intermittent claudication. The study was approved by the local research ethics committee from the Atrium medical centre Heerlen, and all patients provided informed consent.

Study protocol
--------------

The study consisted of two parts. In the first part, 57 patients were included who performed two standardised treadmill tests within three weeks. Patients rested for 10 minutes before each test to ensure that no claudication pain was present at the start. Handrail support was not allowed. In case of unbalance, the researcher gave the patient his hand to hold on to until balance was regained. During the treadmill tests, patients were blinded for the distance/time walked by covering the display of the treadmill. The data from the first part were used to determine reliability of ICD, FCD, and ACD.

In the second part, 25 patients were included who all performed a standardised treadmill test and filled out a Rand-36 questionnaire to determine quality of life. The Rand-36 is a general quality of life questionnaire and determines quality of life in 9 domains of functioning\[[@B22]\]. Data from the second part were used to determine validity of FCD, compared to ICD and ACD.

Treadmill testing
-----------------

A progressive treadmill test was used according to Gardner et al\[[@B23]\]. with a constant speed of 3.2 km/h and an increase in inclination of 2% every two minutes, beginning with 0% inclination. The inclination and testing duration were maximised to 10% and 30 minutes (1600 metres), respectively. Patients participating in the first part of the study performed two treadmill tests. Patients participating in the second part performed only one treadmill test. During treadmill testing all patients were supervised by one of two independent researchers. At each test all walking distances (ICD, FCD, and ACD) were measured. Patients indicated the onset of claudication pain, the point of preferring to stop, and the point that maximum walking distance was reached.

Analysis
--------

Nominal and interval variables are presented as frequency (%) and mean ± standard deviation respectively, unless otherwise indicated. Differences in baseline characteristics between the two groups were assessed by a Chi-square test for nominal variables and a Paired Student\'s T-test for interval variables.

To determine the reliability of ICD, FCD, and ACD, an intra-class correlation coefficient (ICC) for absolute agreement was calculated, according to a two-way mixed effects model with random effects for subjects and a fixed effect for time\[[@B24]\]. Bland-Altman plots were used to visualize the repeated measurements\[[@B25]\]. Regression analysis was applied to assess whether the difference between the two measurements is dependent on the mean walking distance to determine if a log transformation of the Bland-Altman plots is necessary. The extent of variability between repeated measurements was assessed by the coefficient of variation for ICD, FCD and ACD separately.

In the validity study scatter plots were used to examine the linearity of the correlation and to detect possible outliers. Walking distance was plotted against the value of the different domains of the Rand-36 questionnaire for each patient individually. Outliers, appearing as points far away from the overall pattern were excluded. Validity was assessed using the Spearman\'s rho to calculate the degree of correlation between ICD, FCD, and ACD and the different domains of the Rand-36 questionnaire. Data were analysed using SPSS 12.0.

Results
=======

In total eighty-two patients were included in this study, of whom 57 in the reliability part and twenty-five in the validity part. The patient characteristics are shown in Table [1](#T1){ref-type="table"}, and as can be seen, no significant differences were present between the two patient groups.

###### 

Clinical characteristics of included patients

  --------------------------------------------------------------------------------------------------------------------------------------------
  **Characteristic**      **Total Population**\   **Patients for reliability analysis**\   **Patients for validity analysis**\   **P-value**
                          **N = 82**              **N = 57**                               **N = 25**                            
  ----------------------- ----------------------- ---------------------------------------- ------------------------------------- -------------
  Male                    49 (59.8%)              36 (63.2%)                               13 (52.0%)                            0.343

  Age (years)             67 ± 10                 68 ± 9                                   65 ± 12                               0.213

  ABI                     0.69 ± 0.19             0.71 ± 0.20                              0.66 ± 0.17                           0.338

  Weight (kg)             76 ± 14                 76 ± 14                                  75 ± 15                               0.797

  Risk factors                                                                                                                   

   Hypertension           60 (78.9%)              39 (76.5%)                               21 (84.0%)                            0.449

   Diabetes Mellitus      20 (26.3%)              10 (19.6%)                               10 (40.0%)                            0.058

   Hypercholesterolemia   43 (56.6%)              25 (49.0%)                               18 (72.0%)                            0.058

  Smoking behaviour                                                                                                              0.669\*

   Current smoking        34 (44.7%)              22 (43.1%)                               12 (48%)                              

   Former smoking         35 (46.1%)              24 (47.1%)                               11 (44.0%)                            

   Never smoked           7 (9.2%)                5 (9.8%)                                 2 (8.0%)                              
  --------------------------------------------------------------------------------------------------------------------------------------------

Kg: Kilograms, ABI: ankle brachial index.

\* Calculated with Kendall\'s-tau test.

For one patient participating in the reliability study no FCD was measured, for reasons unknown, resulting in 56 patients available for the reliability analysis of FCD.

The mean walking distances (ICD, FCD, and ACD) are shown in Table [2](#T2){ref-type="table"}. For every patient the FCD laid in between ICD and ACD. The mean difference between FCD and ACD was 104 and 106 metres for the first and second treadmill test respectively.

###### 

Mean walking distances and reliability measurements

  -------------------------------------------------------------------------------------------------------------------------------
        **Measurement one (metres)**   **Measurement two (metres)**   **ICC Value (95% CI)**   **Coefficient of variation (%)**
  ----- ------------------------------ ------------------------------ ------------------------ ----------------------------------
  ICD   271.6 ± 174.9                  273.7 ± 162.2                  0.940\                   21.7%
                                                                      (0.899 -- 0.964)         

  FCD   531.2 ± 357.3                  541.2 ± 339.6                  0.959\                   18.8%
                                                                      (0.931 -- 0.976)         

  ACD   635.4 ± 376.0                  642.6 ± 368.8                  0.975\                   13.2%
                                                                      (0.957 -- 0.985)         
  -------------------------------------------------------------------------------------------------------------------------------

SD: standard deviation, ICC: intra-class correlation coefficient, CI: confidence interval, ICD: initial claudication distance, FCD: functional claudication distance, ACD: absolute claudication distance

Figure [1A, B](#F1){ref-type="fig"}, and [1C](#F1){ref-type="fig"} show Bland-Altman plots of ICD, FCD and ACD, respectively. The mean value of 2 measurements is plotted against the difference of measurement 1 minus measurement 2. Regression analysis did not show that systematic differences between repeated measurements were dependent on mean walking distance, indicating that a log transformation of the Bland-Altman plots was unnecessary\[[@B25]\]. Differences between repeated measurements as presented in the Bland-Altman plots are equally divided above and below zero difference. This shows that no learning/therapy effect occurred between the two measurements.

![**Walking distances, represented by Bland-Altman plots**. For ICD, FCD and ACD respectively, the mean of the two measurements is plotted against the difference between the two measurements.](1471-2261-9-9-1){#F1}

The reliability measurements presented in Table [2](#T2){ref-type="table"} show that the ICC of ACD (0.975, 95% CI 0.957 -- 0.985) was significantly better than the ICC of ICD (0.940, 95% CI 0.899 -- 0.964). The ICC of FCD was set in between these two, with a value of 0.959 (95% CI 0.931 -- 0.976), not significantly different from ICD or ACD. The coefficients of variation showed corresponding results with values of 21.7%, 18.1% and 13.2% for the ICD, FCD and ACD, respectively.

Based on the scatter plots two patients were identified as outliers and excluded from the analysis, leaving 23 patients for validity analysis. The mean scores of the Rand-36 questionnaire and the correlations of the different walking distances with quality of life are shown in table [3](#T3){ref-type="table"}. The ICD correlated significantly with the physical function (rho = 0.473, p = 0.022) and general health (rho = 0.518, p = 0.011) domain of the Rand-36 questionnaire. FCD correlated significantly with five out of nine domains, namely physical function (rho = 0.571, p = 0.004)), physical role (rho = 0.532, p = 0.009), vitality (rho = 0.416, p = 0.048), pain (rho = 0.416, p = 0.037) and health change (rho = 0.414, p = 0.050). ACD correlated with physical function (rho = 0.496, p = 0.016), physical role (rho = 0.519, p = 0.011) and health change (rho = 0.446, p = 0.033).

###### 

Rand-36 scores and Spearman\'s correlations with walking distances

  **Domain**          **Rand-36 score**        **ICD**   **FCD**   **ACD**                       
  ------------------- ------------------------ --------- --------- ----------- ------- --------- -------
  Physical function   55.6 (50.0 -- 72.2)      0.473\*   0.022     0.571\*\*   0.004   0.496\*   0.016
  Social function     87.5 (75.0 -- 100.0)     -0.046    0.836     0.001       0.998   -0.065    0.768
  Physical role       75.0 (0.0 -- 100.0)      0.407     0.054     0.532\*\*   0.009   0.519\*   0.011
  Emotional role      100.0 (100.0 -- 100.0)   0.068     0.758     0.157       0.476   0.121     0.584
  Mental health       84.0 (64.0 -- 92.0)      0.014     0.948     0.132       0.549   0.092     0.676
  Vitality            60.0 (55.0 -- 70.0)      0.152     0.488     0.416\*     0.048   0.366     0.086
  Pain                67.3 (55.1 -- 69.4)      0.338     0.114     0.437\*     0.037   0.352     0.099
  General health      50.0 (40.0 -- 60.0)      0.518\*   0.011     0.392       0.065   0.371     0.081
  Health change       50 (25.0 -- 75.0)        0.382     0.072     0.414\*     0.050   0.446\*   0.033

IQR: inter quartile range, ICD: initial claudication distance, FCD: functional claudication distance, ACD: absolute claudication distance.

\* Correlation is significant at the 0.05 level,

\*\* Correlation is significant at the 0.01 level.

Discussion
==========

FCD, defined as the distance when the patient prefers to stop due to claudication, is a reliable and valid measurement to determine functional impairment in patients with intermittent claudication.

The ICC of FCD was 0.959 and in between of the ICC of ICD and ACD, with ACD showing the most reproducible measurements. The coefficients of variation showed corresponding results. ACD showed the least variation, followed by FCD and ICD, respectively.

FCD correlated significantly with the physical function, physical role, vitality, pain and health change domain of the Rand-36 questionnaire. ICD correlated significantly with the physical function and general health domain. Significant correlations of ACD were found with physical function, physical role, and health change. These results indicate that FCD corresponds best with general quality of life as FCD correlated with five of nine domains compared to two and three domains for ICD and ACD respectively.

In our study, ACD is the most reliable measurement during a treadmill test. This conforms to results found in literature for several treadmill protocols \[[@B7]-[@B13]\]. Three studies from Gardner et al\[[@B10],[@B23]\] and Labs et al\[[@B11]\] assessed the reliability of the treadmill protocol used in this study. The ICC of ICD and ACD in these studies ranges from 0.82 to 0.89 and from 0.93 to 0.96, respectively. The coefficients of variation in these studies range from 11.0% to 15.5% for ACD, and from 15.8% to 28.6% for ICD. These findings are in line with coefficients of variation found in our study, and indicate that ICD and ACD are both reliable measurements. However, the ICC found in our study tends to be better than those previously described in the literature. One possible explanation for this difference could be that our test population consisted of patients familiar with treadmill testing. Prior to this study, all patients received at least 3 months of community based supervised exercise therapy, consisting mainly of treadmill walking. This may have influenced the stability of the outcomes of the treadmill tests. It seems plausible that reliability between two measurements increases with treadmill training of the patients, as compared to untrained patients.

In our study FCD correlates best with quality of life, followed by ACD and ICD. In literature several studies determined correlations between QOL and walking distances. A recent study in 48 patients from Myers et al\[[@B16]\] showed a significant correlation of ICD with both pain and social function whereas ACD correlated with physical function and vitality measured by the short-form-36. Izquierdo-Porrera et al\[[@B15]\] determined Pearson\'s correlation coefficients between ACD and the different domains of the short-form-36. In this study ACD correlated significantly with physical function (r = 0.43), physical role (r = 0.33), and mental health (r = 0.27). Furthermore, ICD and ACD correlate with different domains of the PAVK-86\[[@B19]\], the CLAUS questionnaire\[[@B17]\], and the VascuQol\[[@B17]\].

Limitation of the study is that we included patients familiar with treadmill walking, what could have influenced the reliability results. FCD results should therefore be measured in other patient populations and until then treated with caution in these populations. However, corresponding coefficients of variation for ICD and ACD from the literature (untrained patients) compared to our study (trained patients) may indicate that the results from this study for FCD can be projected to patients unfamiliar with treadmill walking.

A further limitation is the limited number of patients included in the validity study (n = 23 for the analysis). A study including more patients to confirm our results is desirable.

The definition of FCD, the distance at which a patient prefers to stop walking, assumes a better reflection of the functional capacity of patients than ICD or ACD. In practice, most patients do not stop walking at the first indication of claudication pain, neither do they walk until they reach their maximal pain threshold. In our study, comparison of FCD with the Rand-36, for the purpose of establishing the clinical relevance shows that FCD correlates better with quality of life than both ICD and ACD. Therefore we think that FCD is a more important outcome measurement from a patient\'s perspective. Furthermore, from a research perspective, FCD is a reliable and valid instrument that can be used in clinical trials. In the future it is conceivable that training programs using a global positioning system will be developed using a software program calculating walking distances and recuperation time\[[@B26]\] Especially in such a training environment it is more likely that the average claudicant will stop when preferring so than until reaching a maximal pain threshold.

Conclusion
==========

The functional claudication distance is a reliable measurement for determining functional capacity in trained patients with intermittent claudication. Furthermore it seems that FCD better reflects the actual functional impairment. In future studies, FCD could be used in conjunction with ICD and ACD.
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